|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aguayo A and Patt YZ: Nonsurgical
treatment of hepatocellular carcinoma. Semin Oncol. 28:503–513.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
Chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuvshinoff BW and Ota DM: Radiofrequency
ablation of liver tumors: influence of technique and tumor size.
Surgery. 132:605–611; discussion 611–612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou BB, Zhang H, Damelin M, et al:
Tumour-initiating cells: challenges and opportunities for
anticancer drug discovery. Nat Rev Drug Discov. 8:806–823. 2009.
View Article : Google Scholar
|
|
9
|
Suetsugu A, Nagaki M, Aoki H, et al:
Characterization of CD133+ hepatocellular carcinoma cells as cancer
stem/progenitor cells. Biochem Biophys Res Commun. 351:820–824.
2006.
|
|
10
|
Yin S, Li J, Hu C, et al: CD133 positive
hepatocellular carcinoma cells possess high capacity for
tumorigenicity. Int J Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma S, Chan KW, Hu L, et al: Identification
and characterization of tumorigenic liver cancer stem/progenitor
cells. Gastroenterology. 132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma S, Lee TK, Zheng BJ, Chan KW and Guan
XY: CD133+ HCC cancer stem cells confer chemoresistance
by preferential expression of the Akt/PKB survival pathway.
Oncogene. 27:1749–1758. 2008.
|
|
13
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar
|
|
14
|
Morel AP, Lièvre M, Thomas C, et al:
Generation of breast cancer stem cells through
epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar
|
|
15
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: new insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gavert N and Ben-Ze’ev A:
Epithelial-mesenchymal transition and the invasive potential of
tumors. Trends Mol Med. 14:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee TK, Poon RT, Yuen AP, et al: Twist
overexpression correlates with hepatocellular carcinoma metastasis
through induction of epithelial-mesenchymal transition. Clin Cancer
Res. 12:5369–5376. 2006. View Article : Google Scholar
|
|
18
|
Li Y, Wicha MS, Schwartz SJ and Sun D:
Implications of cancer stem cell theory for cancer chemoprevention
by natural dietary compounds. J Nutr Biochem. 22:799–806. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Zhang T, Korkaya H, et al:
Sulforaphane, a dietary component of broccoli/broccoli sprouts,
inhibits breast cancer stem cells. Clin Cancer Res. 16:2580–2590.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rausch V, Liu L, Kallifatidis G, et al:
Synergistic activity of sorafenib and sulforaphane abolishes
pancreatic cancer stem cell characteristics. Cancer Res.
70:5004–5013. 2010. View Article : Google Scholar
|
|
21
|
Haidara K, Zamir L, Shi QW and Batist G:
The flavonoid Casticin has multiple mechanisms of tumor
cytotoxicity action. Cancer Lett. 242:180–190. 2006. View Article : Google Scholar
|
|
22
|
Zhou Y, Peng Y, Mao QQ, et al: Casticin
induces caspase-mediated apoptosis via activation of mitochondrial
pathway and upregulation of DR5 in human lung cancer cells. Asian
Pac J Trop Med. 6:372–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kobayakawa J, Sato-Nishimori F, Moriyasu M
and Matsukawa Y: G2-M arrest and antimitotic activity mediated by
casticin, a flavonoid isolated from Viticis Fructus (Vitex
rotundifolia Linne fil.). Cancer Lett. 208:59–64. 2004. View Article : Google Scholar
|
|
24
|
Ko WG, Kang TH, Lee SJ, et al:
Polymethoxyflavonoids from Vitex rotundifolia inhibit proliferation
by inducing apoptosis in human myeloid leukemia cells. Food Chem
Toxicol. 38:861–865. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin S, Zhang H, Han T, Wu JZ, Rahman K and
Qin LP: In vivo effect of casticin on acute inflammation. Zhong Xi
Yi Jie He Xue Bao. 5:573–576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Yang Y, Tian L, Sheng XF, Liu F
and Cao JG: Casticin-induced apoptosis involves death receptor 5
upregulation in hepatocellular carcinoma cells. World J
Gastroenterol. 17:4298–4307. 2011. View Article : Google Scholar
|
|
27
|
He L, Yang X, Cao X, Liu F, Quan M and Cao
J: Casticin induces growth suppression and cell cycle arrest
through activation of FOXO3a in hepatocellular carcinoma. Oncol
Rep. 29:103–108. 2013.
|
|
28
|
El-Haibi CP, Bell GW, Zhang J, et al:
Critical role for lysyl oxidase in mesenchymal stem cell-driven
breast cancer malignancy. Proc Natl Acad Sci USA. 109:17460–17465.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barr MP, Gray SG, Hoffmann AC, et al:
Generation and characterisation of cisplatin-resistant non-small
cell lung cancer cell lines displaying a stem-like signature. PLoS
One. 8:e541932013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gavert N and Ben-Ze’ev A:
Epithelial-mesenchymal transition and the invasive potential of
tumors. Trends Mol Med. 14:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: migrating cancer stem cells - an
integrated concept of malignant tumour progression. Nat Rev Cancer.
5:744–749. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song W, Li H, Tao K, et al: Expression and
clinical significance of the stem cell marker CD133 in
hepatocellular carcinoma. Int J Clin Pract. 62:1212–1218. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar
|
